Gene Therapy for Type 2 Diabetes Enters Human Trial

Dutch regulators have cleared the first human trial of an experimental gene therapy for type 2 diabetes, allowing Fractyl Health to test whether a one-time treatment could reduce reliance on drugs such as Ozempic and Wegovy.[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.